T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones—optimization, design and synthesis

A series of spiro-azetidines and azetidinones has been evaluated as novel blockers of the T-type calcium channel (CaV3.2) which is a new therapeutic target for the potential treatment of both inflammatory and neuropathic pain. Confirmation and optimization of the potency, selectivity and DMPK proper...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2010-08, Vol.20 (15), p.4602-4606
Hauptverfasser: Smith, Elizabeth M., Sorota, Steve, Kim, Hyunjin M., McKittrick, Brian A., Nechuta, Terry L., Bennett, Chad, Knutson, Chad, Burnett, Duane A., Kieselgof, Jane, Tan, Zheng, Rindgen, Diane, Bridal, Terry, Zhou, Xiaoping, Jia, Yu-Ping, Dong, Zoe, Mullins, Debbie, Zhang, Xiaoping, Priestley, Tony, Correll, Craig C., Tulshian, Deen, Czarniecki, Michael, Greenlee, William J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of spiro-azetidines and azetidinones has been evaluated as novel blockers of the T-type calcium channel (CaV3.2) which is a new therapeutic target for the potential treatment of both inflammatory and neuropathic pain. Confirmation and optimization of the potency, selectivity and DMPK properties of leads will be described.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2010.06.012